Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

21 Aug 2018 15:28

RNS Number : 4726Y
Sensyne Health PLC
21 August 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Sensyne Health Ltd

Sedol BYV3J75

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Placing of shares

X

3. Details of person subject to the notification obligationiv

Name

1Lansdowne Partners International Limited

2Lansdowne Partners Limited

3Lansdowne Partners (UK) LLP

4Lansdowne Developed Markets Master Fund Limited

 

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Aurora Nominees Ltd

Morgan Stanley Client Securities Nominees Ltd

(Registered Shareholders)

City and country of registered office (if applicable)

n/a

5. Date on which the threshold was crossed or reachedvi:

17/08/2018

6. Date on which issuer notified (DD/MM/YYYY):

20/08/2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

10.41%

10.41%

128,571,514

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BYV3J755

13,384,497

10.41%

SUBTOTAL 8. A

13,384,497

10.41%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Lansdowne Partners

International Limited

10.41%

10.41%

Lansdowne Partners

Limited

Lansdowne Partners (UK) LLP

10.41%

10.41%

Lansdowne Developed Markets Master Fund Limited

9.03%

9.03%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London

Date of completion

20 August 2018

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLZMGZRDMVGRZM
Date   Source Headline
20th Jun 20227:00 amRNSCancellation - Sensyne Health plc
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:36 pmRNSPrice Monitoring Extension
15th Jun 20226:00 pmRNSSensyne Health
15th Jun 202211:00 amRNSPrice Monitoring Extension
14th Jun 20222:05 pmRNSSecond Price Monitoring Extn
14th Jun 20222:00 pmRNSPrice Monitoring Extension
14th Jun 202211:05 amRNSSecond Price Monitoring Extn
14th Jun 202211:00 amRNSPrice Monitoring Extension
14th Jun 20229:00 amRNSPrice Monitoring Extension
8th Jun 20224:40 pmRNSSecond Price Monitoring Extn
8th Jun 20224:35 pmRNSPrice Monitoring Extension
6th Jun 202212:46 pmRNSResults of General Meeting
19th May 202211:05 amRNSSecond Price Monitoring Extn
19th May 202211:00 amRNSPrice Monitoring Extension
18th May 20225:12 pmRNSPublication of circular, notice of general meeting
17th May 20222:06 pmRNSSecond Price Monitoring Extn
17th May 20222:00 pmRNSPrice Monitoring Extension
3rd May 20223:24 pmRNSHolding(s) in Company
28th Apr 20224:40 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
21st Apr 20222:05 pmRNSSecond Price Monitoring Extn
21st Apr 20222:00 pmRNSPrice Monitoring Extension
19th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
19th Apr 202211:05 amRNSSecond Price Monitoring Extn
19th Apr 202211:00 amRNSPrice Monitoring Extension
19th Apr 20229:53 amRNSForm 8.3 - Sensyne Health Plc
19th Apr 20228:54 amRNSForm 8.5 (EPT/RI)
19th Apr 20227:00 amRNSAmendments to Financing
14th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
14th Apr 20229:21 amRNSForm 8.5 (EPT/RI) - Sensyne Health PLC
13th Apr 20225:00 pmEQSForm 8.3 - Lupus alpha Asset Management AG: Sensyne Health PLC
13th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
13th Apr 20229:27 amRNSForm 8.5 (EPT/RI)
12th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
12th Apr 20228:31 amRNSForm 8.5 (EPT/RI)
12th Apr 20227:00 amRNSHoldings in Company
11th Apr 20222:00 pmRNSPrice Monitoring Extension
11th Apr 20221:36 pmRNSForm 8.3 - Sensyne Health plc
11th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
11th Apr 202210:34 amRNSForm 8.3 - Sensyne Health plc
11th Apr 20229:34 amRNSForm 8.5 (EPT/RI) - Sensyne Health PLC
11th Apr 20229:07 amRNSForm 8.3 - Sensyne Health Plc
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
8th Apr 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
8th Apr 20229:05 amRNSSecond Price Monitoring Extn
8th Apr 20229:00 amRNSPrice Monitoring Extension
8th Apr 20227:00 amRNSBoard Change and Updates on Financing and FSP
7th Apr 20221:23 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.